Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.

Journal of immunology (Baltimore, Md. : 1950) - 1 Apr 1999

Zhang G X, Xiao B G, Bai X F, van der Meide P H, Orn A, Link H

Abstract excerpt

IFN-gamma can either adversely or beneficially affect certain experimental autoimmune diseases. To study the role of IFN-gamma in the autoantibody-mediated experimental autoimmune myasthenia gravis (EAMG), an animal model of myasthenia gravis in humans, IFN-gammaR-deficient (IFN-gammaR-/-) mutant C57BL/6 mice and congenic wild-type mice were immunized with Torpedo acetylcholine receptor (AChR) plus CFA....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Affinity
Share to Immune Sera
Share to Immunization, Passive

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunoglobulin Isotypes

Share to Interferon gamma Receptor

Share to Myasthenia Gravis

Share to Receptors, Cholinergic

Share to Receptors, Interferon

Source

Identifiers

PMID: 10201893

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.PMID 10201893Read ↗

Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.Semantic proximity Read ↗

Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.Semantic proximity Read ↗

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis.Semantic proximity Read ↗

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.Semantic proximity Read ↗

Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.Semantic proximity Read ↗

Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.Semantic proximity Read ↗

Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.Semantic proximity Read ↗

Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.Semantic proximity Read ↗

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.